The SAM electrophysiology market is expected to grow from US$ 501.31 million in 2022 to US$ 853.82 million by 2028; it is estimated to grow at a CAGR of 9.3% from 2022 to 2028.
The geriatric population is prone to various ailments, such as abdominal discomfort and cardiovascular disease. The growing aging population base and the increasing prevalence of cardiac arrhythmia are a few of the major factors driving the electrophysiology market growth. Electrophysiological devices are used to diagnose these disorders in the geriatric population. According to the World Health Organization (WHO), the geriatric population worldwide will grow from ~1 billion in 2019 to ~2.1 billion by 2050. Therefore, market players are developing effective products to cater to the growing patient population that will benefit the electrophysiology market growth.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM electrophysiology market at a substantial CAGR during the forecast period.
The geriatric population is prone to various ailments, such as abdominal discomfort and cardiovascular disease. The growing aging population base and the increasing prevalence of cardiac arrhythmia are a few of the major factors driving the electrophysiology market growth. Electrophysiological devices are used to diagnose these disorders in the geriatric population. According to the World Health Organization (WHO), the geriatric population worldwide will grow from ~1 billion in 2019 to ~2.1 billion by 2050. Therefore, market players are developing effective products to cater to the growing patient population that will benefit the electrophysiology market growth.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM electrophysiology market at a substantial CAGR during the forecast period.
SAM Electrophysiology Market Segmentation
The SAM electrophysiology market is segmented based on product, indication, and country.- Based on product, the market is segmented into electrophysiology ablation catheters, electrophysiology laboratory devices, electrophysiology diagnostic catheters, access devices, and others. The electrophysiology laboratory devices segment dominated the market in 2022 and electrophysiology ablation catheters segment is expected to be fastest growing during forecast period.
- Based on indication, the market is segmented into atrial fibrillation (AF), atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), wolff-parkinson-white syndrome (WPW), and others. The atrial fibrillation (AF) segment dominated the market in 2022 and is expected to be fastest growing during forecast period.
- Based on country, the SAM electrophysiology market is segmented into Brazil, Argentina, and the Rest of SAM.
Table of Contents
1. Introduction
3. Research Methodology
4. SAM Electrophysiology Market - Market Landscape
5. Electrophysiology Market- Key Market Dynamics
6. Electrophysiology Market- SAM Analysis
7. SAM Electrophysiology Market Analysis - By Product
8. SAM Electrophysiology Market Analysis - By Indication
9. SAM Electrophysiology Market - Country Analysis
10. SAM Electrophysiology Market-Industry Landscape
11. Company Profiles
12. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott
- Biotronik, Inc.
- Boston Scientific Corporation
- CardioFocus
- GE Healthcare
- Johnson & Johnson Services, Inc.
- Koninklijke Philips N.V.
- Medtronic
- MicroPort Scientific Corporation
- Siemens Healthineers AG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 131 |
| Published | September 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 501.31 Million |
| Forecasted Market Value ( USD | $ 853.82 Million |
| Compound Annual Growth Rate | 9.3% |
